Is IMOS a Buy? What to Consider in 2026

Short answer

The bull case for ChipMOS Technologies provides back-end semiconductor services: it assembles and tests chips for fabless designers (IMOS) rests on AI-driven memory demand: ChipMOS reported first-quarter 2026 revenue of about NT$6.9 billion (roughly US$216 million), up around 25 percent year over year, driven by a persistent AI-related demand and supply imbalance for high-value memory solutions. Revenue (TTM) is ~$792M. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: ChipMOS is a small OSAT competing against giants like ASE and Amkor and specialist peers like Powertech, so it lacks their scale, diversification, and pricing power. Whether IMOS is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.

ChipMOS Technologies provides back-end semiconductor services: it assembles and tests chips for fabless designers, integrated device manufacturers, and foundries. Its specialties include memory packaging and testing plus a leading position in chip-on-film (COF) packaging for display driver integrated circuits (DDICs) used in smartphone and TV panels, alongside services like wafer bumping, ball grid array (BGA), and wafer-level chip-scale packaging. The company runs facilities in Taiwan's Hsinchu and Southern Taiwan science parks and is listed both in Taipei (8150) and on Nasdaq as an ADR (IMOS). The investment picture is one of deep cyclicality layered under a current AI tailwind. ChipMOS is a small player (roughly $700 to $800 million in annual revenue) competing against far larger OSAT firms, so its margins and earnings swing hard with memory prices and consumer-electronics demand. Reported net profit fell sharply in 2025 even as revenue set records, but the AI-driven demand and supply imbalance for high-value memory has pushed quarterly revenue up strongly into 2026, and the ADR has re-rated dramatically over the past year. The result is a volatile stock priced on a hoped-for continuation of the memory and packaging upcycle rather than steady earnings.

What's the case for buying IMOS?

1. AI-driven memory demand

ChipMOS reported first-quarter 2026 revenue of about NT$6.9 billion (roughly US$216 million), up around 25 percent year over year, driven by a persistent AI-related demand and supply imbalance for high-value memory solutions. Data-center and AI applications are pulling through more advanced memory packaging and test volume, which is the core reason the stock re-rated.

2. Chip-on-film and display-driver niche

The company is a global leader in COF packaging for display driver ICs, a specialized niche tied to smartphone, TV, and panel demand. This gives it a defensible position in a corner of the market that larger OSAT firms do not dominate, though it also concentrates exposure to consumer-electronics cycles.

3. Capacity, cash, and shareholder returns

ChipMOS carried a large cash balance (reported cash and equivalents of roughly NT$14.9 billion at the end of 2025) and returns capital through dividends and buybacks. It has proposed a distribution from capital surplus, and the trailing buyback yield has been meaningful, supporting the shares while it invests in capacity for higher-value packaging.

4. Leverage to a broader OSAT upcycle

As a back-end specialist, ChipMOS benefits when overall chip volumes and complexity rise, since testing and advanced packaging take a growing share of semiconductor value. Continued recovery in memory pricing and utilization would flow quickly to its margins given its operating leverage.

What are the risks to IMOS?

ChipMOS is a small OSAT competing against giants like ASE and Amkor and specialist peers like Powertech, so it lacks their scale, diversification, and pricing power. Its revenue is concentrated in two volatile end-markets, memory and consumer display drivers, meaning a downturn in smartphone sales or memory prices hits results directly and severely. Net profit already fell sharply in 2025 on higher non-operating expenses and lower operating profit, and gross margins are thin (around the low teens), so earnings are highly cyclical. As a Taiwan-based ADR, the stock also carries currency, geopolitical, and cross-listing risks, and after a very large one-year run the shares trade at a rich trailing valuation that assumes the memory and AI upcycle persists.

How is IMOS valued? (as of JULY 2026)

Price
$64.93
Market cap
$2.26B
P/E (TTM)
83.25
Forward P/E
64.29
Price / book
2.95
Beta
1.30
52-week range
$15.06 to $73.97

Snapshot for IMOS as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

  • Revenue (TTM): ~$792M
  • Net income (TTM): ~$26M
  • Gross margin: ~12%
  • Market cap: ~$2.5B
  • P/E (trailing / forward): ~98 / ~26
  • Dividend yield: ~1.1%

The trailing P/E looks extreme (near 98) because 2025 net profit fell about 65 percent year over year, compressing the earnings base, while the forward P/E of roughly 26 reflects expected recovery. The ADR rose more than 280 percent over the trailing 52 weeks on the AI memory upcycle, so the valuation now embeds a continued rebound in packaging and test demand.

How do you decide if IMOS is a buy?

Rather than asking whether IMOS is a buy in the abstract, it tends to help to answer four questions:

  • Thesis: do you believe the case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold IMOS indirectly through an index or sector ETF before adding more.

For the full picture, see the IMOS stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about IMOS against your real portfolio and see your actual exposure before deciding.

The bottom line on IMOS

The bottom line: ChipMOS Technologies provides back-end semiconductor services: it assembles and tests chips for fabless designers's story right now is AI-driven memory demand, with revenue (ttm) at ~$792M. If you believe that narrative continues, the call is about sizing IMOS sensibly and checking overlap with what you own; if you doubt it (the risk: chipMOS is a small OSAT competing against giants like ASE and Amkor and specialist peers like Powertech, so it lacks their scale, diversification, and pricing power.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.

Build a basket around IMOS with Walnut

Use ChipMOS Technologies provides back-end semiconductor services: it assembles and tests chips for fabless designers as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.

FAQ

Is IMOS a good stock to buy right now?

+

The case for ChipMOS Technologies provides back-end semiconductor services: it assembles and tests chips for fabless designers right now is AI-driven memory demand, with revenue (ttm) at ~$792M. If you believe that thesis holds, IMOS is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is chipMOS is a small OSAT competing against giants like ASE and Amkor and specialist peers like Powertech, so it lacks their scale, diversification, and pricing power. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.

What does ChipMOS Technologies provides back-end semiconductor services: it assembles and tests chips for fabless designers do?

+

ChipMOS Technologies provides back-end semiconductor services: it assembles and tests chips for fabless designers, integrated device manufacturers, and foundries.

What are the main risks of IMOS?

+

ChipMOS is a small OSAT competing against giants like ASE and Amkor and specialist peers like Powertech, so it lacks their scale, diversification, and pricing power. Its revenue is concentrated in two volatile end-markets, memory and consumer display drivers, meaning a downturn in smartphone sales or memory prices hits results directly and severely. Net profit already fell sharply in 2025 on higher non-operating expenses and lower operating profit, and gross margins are thin (around the low teens), so earnings are highly cyclical. As a Taiwan-based ADR, the stock also carries currency, geopolitical, and cross-listing risks, and after a very large one-year run the shares trade at a rich trailing valuation that assumes the memory and AI upcycle persists.

What does ChipMOS Technologies actually do?

+

It is an outsourced semiconductor assembly and test (OSAT) provider. ChipMOS packages and tests chips for other companies, specializing in memory packaging and testing and in chip-on-film packaging for display driver ICs used in smartphone and TV panels.

Is IMOS a US company?

+

No. ChipMOS is headquartered in Taiwan with facilities in Hsinchu and Southern Taiwan science parks. It trades on the Taiwan Stock Exchange as 8150 and lists on Nasdaq as an American Depositary Receipt (ADR) under the ticker IMOS.

Why has the IMOS stock price moved so much?

+

The ADR rose more than 280 percent over the trailing year (as of July 2026) on an AI-driven memory demand and supply imbalance that lifted revenue. As a small-cap semiconductor stock, it is high-beta and swings sharply with the memory and packaging cycle.

Does ChipMOS pay a dividend?

+

Yes. ChipMOS has a history of returning capital through dividends and buybacks. As of July 2026 the dividend yield was around 1 percent, and the company proposed a distribution from capital surplus (about NT$1.23 per common share) pending shareholder approval.

Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell IMOS; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.

Related stocks

    Is IMOS a Buy? What to Consider in 2026, Walnut